Established Cell Therapies an a JCI-accredited hospital.

Transplant-grade cell therapy where the evidence is strong, supportive treatment where it’s reasonable, and a clear no where it’s neither.

“Regenerative medicine” covers two very different things. On one side sit cell therapies with decades of trial data and formal approval — bone marrow and stem-cell transplantation for blood cancers, CAR-T for specific lymphomas and leukaemias. On the other sits an international market selling unproven stem-cell infusions for arthritis, MS and ageing, at prices that have nothing to do with evidence. We work at the first end, plus a middle ground of supportive treatments like PRP, where we say plainly how much benefit to actually expect. If you’ve been quoted a stem-cell cure for something no cure exists for, we’ll tell you that too.

Ready to Take the Next Step?

Why Florence Nightingale for Regenerative Treatment?

Accredited transplant infrastructure. Honest evidence grading. A department willing to say no.

  • An established bone marrow and stem-cell transplantation programme inside a JCI-accredited hospital
  • Multidisciplinary review — haematology, oncology, orthopaedics — rather than one practitioner selling one technique
  • Every proposal graded by evidence, so you know if it’s standard of care, reasonable but modest, or experimental
  • Cell-based treatment restricted strictly to what Türkiye’s regulations actually permit
  • CAR-T cell therapy for approved blood cancer indications, with the intensive care support it requires
  • Full international coordination: visa invitation letter, transfers, accommodation, interpreters.

What We Offer at Florence Nightingale?

A Guide On Regenerative Medicine Claims

A legitimate provider can name the cell type, the source and the approval it’s administered under. Vague language like “regenerative cells” usually means the specifics wouldn’t survive scrutiny.

Approved cell therapies are approved for named conditions, not categories of illness. A long, unrelated disease list is marketing, not medicine.

Before-and-after photos and conference talks aren’t evidence. Ask for trial data in your specific condition.

It may ease pain in mild-to-moderate knee arthritis for a few months. It doesn’t regenerate cartilage or postpone a replacement you genuinely need.

We review regenerative medicine quotes from other providers at no charge — even when our honest conclusion is that you shouldn’t travel for it at all.

What to Expect as an International Patient

Before You Arrive

  • Share your diagnosis, imaging and previous treatment records
  • Case reviewed by the relevant specialist team
  • A written opinion on whether cell-based treatment is indicated — or not

Assessment & Planning

  • In-person consultation and any further testing needed
  • Multidisciplinary review against approved indications
  • Full discussion of risks, alternatives and cost before consent

Treatment

  • Cell therapies delivered in the accredited transplant unit
  • Supportive procedures performed as image-guided outpatient treatment
  • Private rooms and 24/7 nursing throughout

Follow Up & Return Home

  • Detailed discharge documentation and monitoring schedule
  • Coordination with your own physician at home
  • Long-term monitoring for transplant and CAR-T patients

Proof You Can See

  • 35+ years of clinical experience across the Group, with around 20,000 operations performed each year
  • JCI-accredited since 2013, now in its fifth accreditation cycle
  • Ratings: 5/5 on Bookimed, 4.7/5 across 6,621 patient responses
  • Multilingual coordinators — English, Arabic, Russian, French, German, Romanian, Serbian and more
  • Direct billing and pre-authorisation with major international insurers

We’ve worked with patients from 100+ countries — no case too simple or complex.

Common Questions

Established cell therapies — stem-cell transplantation and CAR-T — for blood and marrow disease, plus supportive treatments like PRP for specific musculoskeletal problems. 

It may ease pain for a few months in mild-to-moderate disease. It doesn’t regrow cartilage, and we’ll tell you plainly when a joint replacement is actually the better option.

No — a transplant rebuilds bone marrow to treat blood disease. It’s not a general repair therapy for joints or organs, though the two get conflated in advertising constantly.

CAR-T re-engineers your own T-cells to attack specific blood cancers. It’s approved for defined lymphoma and leukaemia types — send your haematology records and we’ll assess your case.

Book Your Consultation or Ask a Question

Let us know what kind of support you need. We’ll be in touch within 24 hours.

Prefer to talk directly